sameAs
Cisplatin/Carboplatin and Etoposide With or Without Nivolumab in Treating Patients With Extensive Stage Small Cell Lung CancerLiposome-encapsulated Daunorubicin-Cytarabine, Fludarabine Phosphate, Cytarabine, and Filgrastim in Treating Younger Patients With Relapsed or Refractory Acute Myeloid LeukemiaDabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by SurgeryLung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung CancerRate Control Versus Rhythm Control For Postoperative Atrial FibrillationPercutaneous Endovascular Aneurysm Repair (PEVAR) TrialAssessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First RemissionIntravenous Lacosamide Compared With Fosphenytoin in the Treatment of Patients With Frequent Nonconvulsive SeizuresPaclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by SurgeryTesting Ramipril to Prevent Memory Loss in People With GlioblastomaCisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After SurgeryFinancial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing TreatmentLong Term Follow Up for CTSN Mitral Valve Repair StudiesAssessment of Fixation Strategies for Severe Open Tibia FracturesWarfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN)Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean InfectionCombination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing SarcomaPembrolizumab in Treating Patients With Locally Advanced Bladder CancerVemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)Paclitaxel, Trastuzumab, and Pertuzumab With or Without Atezolizumab in Treating Patients With Metastatic Breast CancerTargeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)Firstline Pembrolizumab Alone or in Combination With Pemetrexed and Carboplatin in Induction/Maintenance or Postprogression in Treating Patients With Stage IV Non-squamous Non-small Cell Lung CancerBlinatumomab in Combination With Chemotherapy in Treating Patients With or Without Down Syndrome and Newly Diagnosed, Standard Risk B-Lymphoblastic Leukemia or Localized B-Lymphoblastic LymphomaComparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With ChemotherapyRadiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and EtoposideIbrutinib and Obinutuzumab With or Without Venetoclax in Treating Patients With Chronic Lymphocytic LeukemiaExemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or MetastaticAxitinib and Nivolumab in Treating Patients With Unresectable or Metastatic TFE/Translocation Renal Cell CarcinomaSorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver CancerPalbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLyFulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-PositiveChemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By SurgeryILLUMENATE Pivotal Post-Approval Study (PAS)Neuropsychological and Behavioral Testing in Younger Patients With CancerResponse and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma
P6153
Q58846742-5E81F99C-B183-4A30-B3D1-6D8B6D25DB0DQ61862222-6966E904-65F6-4D59-BC33-23544FA7BE8DQ61864729-EC14EA2D-99C2-4025-AB6A-D6D66746A2D1Q61865593-B706DCF5-B81E-429C-B675-6C66A499A58AQ61894217-2B245CE1-5659-4240-92AF-4BBD1C010228Q61938855-B3BAB219-3DF5-4812-8262-A88078E83D4FQ61957392-A7328E73-8EF9-42DF-BB3F-34E1325C28DDQ61965868-9C448F74-E98C-4E6D-B43D-1508997F754AQ61981377-4328CEFA-0E51-402F-AC55-E4C9BB99A2A0Q62814121-58D5B372-C158-485E-857B-3D503C8CB014Q62815257-0EE2A1C7-0DAA-4B3E-A2FA-E69C628D2F4CQ62817334-D9878C69-7545-436A-A648-63C5232D069EQ63229483-581D64CF-CBC4-4E6F-ABD1-6378D37EA1D7Q63319694-D84A2047-0C78-4222-A7FF-E16B9BBC7CB2Q63336484-0CAF0775-C71E-46B5-9577-409E92B1327DQ63340739-583E0D6D-B844-4AD2-BB0D-E515331A720BQ63341046-2F83A075-E448-407D-BEA3-9F000CA5286FQ63572983-C3EABC5C-213B-4BB1-9CFF-7B2647FB36CAQ63573040-1A01EEAE-DEFA-4940-903D-4A65EABC15BDQ63573128-0EC83333-CC9A-4D6B-BC93-A0B199D440D9Q63573228-908026E1-5253-444A-9FF5-C356478416E7Q63575200-E277EAA5-78B6-4ACE-8F5B-019FBC34D292Q63578202-AD8FE32B-A802-4E4C-B637-6E6AC53F5330Q64123525-A153B2A4-1AB7-4F4E-81FE-A3644F8B802DQ64123696-1F34A0CE-FB8E-4421-8E5E-25B42C2D81F5Q64150388-6CCDAA06-73B1-4AB8-A9DE-DC154354C1EDQ64150411-9DF8DEAA-DBED-472A-98C3-C2A9E27E875FQ64150452-4B56AFAF-AEBD-4943-8243-E855494A3991Q64150545-377EF302-6C25-4CCF-8A48-DF9479E7B776Q64150599-F66774D0-8D25-45B3-9F04-D513CBBC795CQ64151264-7E4AD1A4-193A-4B88-94ED-CF6F2D390EC4Q64170973-395754EA-4EBB-4D33-8D02-95B07CE73198Q64171079-F2463F8B-E024-402F-9C70-3DE94587D700Q64171497-07C0B7A3-678D-4F31-830A-0D6BF01420C2Q64172725-E618EA2E-E316-4F1E-BEF6-1EC9FE6BE15CQ64172995-CC7386FA-2FB8-4C11-B994-AE04A14DABAF
P6153
description
Krankenhaus
@de
griya sakit
@jv
hospital d'Estaos Xuníos
@ast
hospital
@en
hôpital
@fr
organisatie uit Verenigde Staten van Amerika
@nl
rumah sakik
@min
rumah sakit di Amerika Serikat
@id
rumoh sakét
@ace
مستشفى
@ar
name
Mission Health System
@en
type
label
Mission Health System
@en
altLabel
Mission Foundation
@en
prefLabel
Mission Health System
@en
P6366
P131
P2002
missionhealthnc
P2427
grid.429672.c
P373
Mission Health System
P571
1885-01-01T00:00:00Z
P6366
1304161147